AI chatbot education for gynecologic cancer patients
Part of Women’s health & pregnancy clinical trials.
This trial uses an AI chatbot to help educate gynecologic oncology patients about HPV vaccination. It aims to see if the chatbot improves knowledge and vaccination rates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient at the LA General gynecologic oncology clinic
- You are 18 years or older
- You speak English or Spanish
- You have previously received the HPV vaccine (for the initial chatbot evaluation) or are eligible for it (for the pilot intervention)
- You are willing and able to provide informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a chatbot can help parents learn about the HPV vaccine and encourage them to get their daughters vaccinated. It is for parents of middle school girls who haven't yet gotten the HPV shot.
This study tests a chatbot that answers questions about the HPV vaccine to help people feel more confident and less hesitant about getting it. You may be eligible if you are a woman aged 15 to 45 and have not yet had the HPV vaccine.
This study tests whether a chatbot (an AI helper you chat with via your phone) can help parents of junior high school girls learn about and decide to get the HPV vaccine for their daughters. The HPV vaccine protects against certain cancers later in life.
This study tests whether a chatbot (like a smart helper on your phone) can help female university students learn about the HPV vaccine, feel more ready to get it, and actually get vaccinated.
This trial tests whether an AI chatbot can encourage women to take part in cervical cancer screening. It targets women who have not had a recent Pap test and who did not respond to an invitation letter, aiming to improve participation.
This trial tests an AI chatbot designed to help educate patients about prostate cancer radiation therapy. It may provide a simple way to answer your questions before treatment.
Hear when a new Gynecologic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.